Be Vigilant When Starting Meds in Patients Taking Hep C Antivirals

You'll face MANY potential drug interactions with hepatitis C antivirals (Epclusa, Mavyret, etc)...even if you didn't start these meds.

Interactions can lead to toxicity...or treatment failure. And this can be an expensive mistake...since antivirals cost up to $95,000/course.

Plus hep C meds may fly under the radar if you didn't prescribe them. Update the EHR with ALL meds...Rxs, OTCs, supplements, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote